This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2017 Feb;26(2):133-136.

doi: 10.1080/13543784.2017.1274392. Epub 2016 Dec 27.

Thoughts on investigational hedgehog pathway inhibitors for the treatment of cancer

Tarkan Jäger¹, Matthias Ocker^{2

3}, Tobias Kiesslich^{4

5}, Elen Neureiter⁶, Daniel Neureiter^{7

8}

Affiliations

Affiliations

¹ a Department of Surgery , Paracelsus Medical University, Salzburger Landeskliniken (SALK) , Salzburg , Austria.
² b Experimental Medicine Oncology , Bayer Pharma AG , Berlin , Germany.
³ c Department of Gastroenterology CBF , Charité University Medicine Berlin , Berlin , Germany.
⁴ d Department of Internal Medicine I , Paracelsus Medical University, Salzburger Landeskliniken (SALK) , Salzburg , Austria.
⁵ e Laboratory for Tumour Biology and Experimental Therapies (TREAT) , Institute of Physiology and Pathophysiology, Paracelsus Medical University , Salzburg , Austria.
⁶ f Faculty of Chemistry , University of Vienna , Vienna , Austria.
⁷ g Institute of Pathology , Paracelsus Medical University, Salzburger Landeskliniken (SALK) , Salzburg , Austria.
⁸ h Cancer Cluster Salzburg (CCS) , Salzburg , Austria.

PMID: 28004600
DOI: 10.1080/13543784.2017.1274392

Editorial

Thoughts on investigational hedgehog pathway inhibitors for the treatment of cancer

Tarkan Jäger et al. Expert Opin Investig Drugs. 2017 Feb.

. 2017 Feb;26(2):133-136.

doi: 10.1080/13543784.2017.1274392. Epub 2016 Dec 27.

Authors

Tarkan Jäger¹, Matthias Ocker^{2

3}, Tobias Kiesslich^{4

5}, Elen Neureiter⁶, Daniel Neureiter^{7

8}

Affiliations

¹ a Department of Surgery , Paracelsus Medical University, Salzburger Landeskliniken (SALK) , Salzburg , Austria.
² b Experimental Medicine Oncology , Bayer Pharma AG , Berlin , Germany.
³ c Department of Gastroenterology CBF , Charité University Medicine Berlin , Berlin , Germany.
⁴ d Department of Internal Medicine I , Paracelsus Medical University, Salzburger Landeskliniken (SALK) , Salzburg , Austria.
⁵ e Laboratory for Tumour Biology and Experimental Therapies (TREAT) , Institute of Physiology and Pathophysiology, Paracelsus Medical University , Salzburg , Austria.
⁶ f Faculty of Chemistry , University of Vienna , Vienna , Austria.
⁷ g Institute of Pathology , Paracelsus Medical University, Salzburger Landeskliniken (SALK) , Salzburg , Austria.
⁸ h Cancer Cluster Salzburg (CCS) , Salzburg , Austria.

PMID: 28004600
DOI: 10.1080/13543784.2017.1274392

No abstract available

Keywords: Hedgehog pathway; drug development; inhibitors.

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations